Drug intelligence / Profile preview

Fuyuan granule

Development stage: Unknown
Lead developer: China Academy of Chinese Medical Sciences
Administration: Oral

Overview

Fuyuan granule is a Traditional Chinese Medicine (TCM) formulation currently undergoing clinical investigation for its potential in treating borderline hypertension. It is administered as a granule and is being studied in a multicenter, randomized, double-blind, placebo-controlled clinical trial.

Other names: 复元方

Beyond the preview

Go deeper on Fuyuan granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fuyuan granule.

Explore the full profile